Adaptimmune Therapeutics | ARS: Annual Report to Security Holders
Apr 22 17:17 ET
Adaptimmune Therapeutics | 8-K: Current report
Apr 12 08:07 ET
Adaptimmune Therapeutics | DEF 14A: Definitive information statements
Apr 11 08:04 ET
Adaptimmune Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-New Enterprise Associates 14, L.P.(6.7%),NEA Partners 14, L.P.(6.7%), etc.
Apr 2 20:41 ET
Adaptimmune Therapeutics | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Apr 1 08:06 ET
Adaptimmune Therapeutics | 3: Initial statement of beneficial ownership of securities-10% Owner EcoR1 Capital, LLC
Mar 26 12:04 ET
Adaptimmune Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-EcoR1 Capital, LLC(10.7%),Oleg Nodelman(10.7%), etc.
Mar 26 12:04 ET
Adaptimmune Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Piccina Cintia
Mar 18 17:01 ET
Adaptimmune Therapeutics | 10-K: Annual report
Mar 6 07:18 ET
Adaptimmune Therapeutics | 8-K: Current report
Mar 6 07:08 ET
Adaptimmune Therapeutics | 8-K: Current report
Feb 27 08:16 ET
Adaptimmune Therapeutics | 8-K: Current report
Feb 16 16:10 ET
Adaptimmune Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Baker Bros. Advisors LP(4.8%),Baker Bros. Advisors (GP) LLC(4.8%), etc.
Feb 14 17:49 ET
Adaptimmune Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-LONG FOCUS CAPITAL MANAGEMENT, LLC(5.3%),JOHN B. HELMERS(5.3%), etc.
Feb 14 17:11 ET
Adaptimmune Therapeutics | 8-K: Current report
Jan 31 17:13 ET
Adaptimmune Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-EcoR1 Capital, LLC(7.7%),Oleg Nodelman(7.7%), etc.
Jan 30 17:29 ET
Adaptimmune Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Baillie Gifford & Co (Scottish partnership)(7.01%)
Jan 29 11:53 ET
Adaptimmune Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Rawcliffe Adrian
Jan 17 00:00 ET
Adaptimmune Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Bertrand William C JR
Jan 17 00:00 ET
Adaptimmune Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Lunger John
Jan 17 00:00 ET
No Data
No Data